Cargando…

A multi-centre cohort study on healthcare use due to medication-related harm: the role of frailty and polypharmacy

OBJECTIVES: To determine the association between frailty and medication-related harm requiring healthcare utilisation. DESIGN: Prospective observational cohort study. SETTING: Six primary and five secondary care sites across South East England, September 2013–November 2015. PARTICIPANTS: One thousan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stevenson, Jennifer M, Parekh, Nikesh, Chua, Kia-Chong, Davies, J Graham, Schiff, Rebekah, Rajkumar, Chakravarthi, Ali, Khalid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966695/ https://www.ncbi.nlm.nih.gov/pubmed/35353136 http://dx.doi.org/10.1093/ageing/afac054

Ejemplares similares

Incidence and cost of medication harm in older adults following hospital discharge: a multicentre prospective study in the UK
por: Parekh, Nikesh, et al.
Publicado: (2018)

Medication-related harm in older adults following hospital discharge: development and validation of a prediction tool
por: Parekh, Nikesh, et al.
Publicado: (2020)

Protocol for a Prospective (P) study to develop a model to stratify the risk (RI) of medication (M) related harm in hospitalized elderly (E) patients in the UK (The PRIME study)
por: Stevenson, Jennifer, et al.
Publicado: (2016)

Characterising older adults’ risk of harm from blood-pressure lowering medications: a sub-analysis from the PRIME study
por: Hussain, Ahmed, et al.
Publicado: (2022)

Hospital pharmacists' opinions on a risk prediction tool for medication‐related harm in older people
por: Hussain, Ahmed, et al.
Publicado: (2022)

Implementation of a medicine management plan (MMP) to reduce medication-related harm (MRH) in older people post-hospital discharge: a randomised controlled trial
por: Ali, Khalid, et al.
Publicado: (2022)

Irbesartan improves arterial compliance more than lisinopril
por: Ali, Khalid, et al.
Publicado: (2009)

Polypharmacy among patients with hypertension attending primary healthcare centres
por: Alsanosi, Safaa M., et al.
Publicado: (2023)

The Need for Actions Against Polypharmacy in Older People With Frailty
por: Kojima, Taro
Publicado: (2018)

A study of harmful drug–drug interactions due to polypharmacy in hospitalized patients in Goa Medical College
por: Khandeparkar, Akshay, et al.
Publicado: (2017)

FRailty and Arterial stiffness – the role of oXidative stress and Inflammation (FRAXI study)
por: Mensah, Ekow, et al.
Publicado: (2022)

Frailty and the Risk of Polypharmacy in the Older Person: Enabling and Preventative Approaches
por: Nwadiugwu, Martin C.
Publicado: (2020)

Drug storage, polypharmacy and frailty syndrome in older people: an observational study
por: Tabué-Téguo, Maturin, et al.
Publicado: (2023)

Opioid toxicity due to CNS depressant polypharmacy: A case report
por: Lee, Christine, et al.
Publicado: (2021)

Polypharmacy, comorbidity and frailty: a complex interplay in older patients at the emergency department
por: van Dam, Carmen S., et al.
Publicado: (2022)

POLYPHARMACY, FRAILTY, AND DISABILITY-FREE SURVIVAL IN COMMUNITY-DWELLING HEALTHY OLDER INDIVIDUALS
por: Ekram, A R M Saifuddin, et al.
Publicado: (2022)

Frailty and Potentially Inappropriate Prescribing in Older People with Polypharmacy: A Bi-Directional Relationship?
por: Randles, Mary A., et al.
Publicado: (2022)

THE EFFECTS OF FRAILTY, POLYPHARMACY, AND COGNITION ON HEALTH OUTCOMES: A STUDY ON INTERRAI RESIDENTIAL CARE DATA
por: Zou, Macy, et al.
Publicado: (2019)

Frailty Status and Polypharmacy Predict All-Cause Mortality in Community Dwelling Older Adults in Europe
por: Midão, Luís, et al.
Publicado: (2021)

Family Conferences to Facilitate Deprescribing in Older Outpatients With Frailty and With Polypharmacy: The COFRAIL Cluster Randomized Trial
por: Mortsiefer, Achim, et al.
Publicado: (2023)

Number of medications and polypharmacy are associated with frailty in older adults: results from the Midlife in the United States study
por: Alqahtani, Bader
Publicado: (2023)

Drug utilization pattern and factors associated with polypharmacy and excessive polypharmacy in geriatric medical out-patients at a rural health training centre in India
por: Nitya, S., et al.
Publicado: (2021)

Defining avoidable healthcare-associated harm in prisons: A mixed-method development study
por: Keers, Richard N., et al.
Publicado: (2023)

A multi-centre, randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations
por: Birchwood, Max, et al.
Publicado: (2011)

Development and Validation of a Risk Model for Predicting Adverse Drug Reactions in Older People during Hospital Stay: Brighton Adverse Drug Reactions Risk (BADRI) Model
por: Tangiisuran, Balamurugan, et al.
Publicado: (2014)

Managing Polypharmacy in Older Adults with Cancer Across Different Healthcare Settings
por: Whitman, Andrew, et al.
Publicado: (2021)

Scoping Review of Studies Evaluating Frailty and Its Association with Medication Harm
por: Lam, Jonathan Yong Jie, et al.
Publicado: (2022)

How is return on investment from quality improvement programmes conceptualised by mental healthcare leaders and why: a qualitative study
por: Thusini, S’thembile, et al.
Publicado: (2023)

Polypharmacy in the elderly
por: Golchin, Negar, et al.
Publicado: (2015)

Acute Encephalopathy Due to Polypharmacy Interactions With the Use of Paxlovid: A Case Report
por: Khan, Samira, et al.
Publicado: (2023)

Polypharmacy Is Associated with Frailty, Nutritional Risk and Chronic Disease in Chilean Older Adults: Remarks from PIEI-ES Study
por: Arauna, Diego, et al.
Publicado: (2020)

Frailty modifies the effect of polypharmacy and multimorbidity on the risk of death among nursing home residents: Results from the SHELTER study
por: Zazzara, Maria Beatrice, et al.
Publicado: (2023)

Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
por: Bighelli, Irene, et al.
Publicado: (2022)

Predicting adverse drug reactions in older adults; a systematic review of the risk prediction models
por: Stevenson, Jennifer M, et al.
Publicado: (2014)

Polypharmacy Is Significantly and Positively Associated with the Frailty Status Assessed Using the 5-Item FRAIL Scale, Cardiovascular Health Phenotypic Classification of Frailty Index, and Study of Osteoporotic Fractures Scale
por: Hung, Chi-Di, et al.
Publicado: (2021)

Predicting parkinsonism side-effects of antipsychotic polypharmacy prescribed in secondary mental healthcare
por: Kadra, Giouliana, et al.
Publicado: (2018)

Implementation frameworks for polypharmacy management within healthcare organisations: a scoping review
por: Al Bulushi, S., et al.
Publicado: (2023)

Correction to: Scoping Review of Studies Evaluating Frailty and Its Association with Medication Harm
por: Lam, Jonathan Yong Jie, et al.
Publicado: (2022)

Gender-specific linkages: frailty, polypharmacy, anti-cholinergic burden, and 5-year mortality risk—a real-world analysis
por: Chou, Yin Yi, et al.
Publicado: (2023)

Harm reduction principles for healthcare settings
por: Hawk, Mary, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_e4vhjdgkrthsdg33a2su2sgvm7